SZSE:301075 (China)
Â
Class A
Â¥
19.05
(-0.88%)
Dec 24
Business Description
Tibet Duo Rui Pharmaceutical Co Ltd
ISIN : CNE100004RW5
Share Class Description:
SZSE:301075: Class ACompare
Compare
Traded in other countries / regions
301075.China IPO Date
2021-09-29Description
Tibet Duo Rui Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical-pharmaceutical preparations and their raw materials.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.66 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.33 | |||||
| Debt-to-EBITDA | -12.38 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 4.38 | |||||
| Beneish M-Score | -1.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19.5 | |||||
| 3-Year EBITDA Growth Rate | -33.5 | |||||
| 3-Year EPS without NRI Growth Rate | -64.4 | |||||
| 3-Year Book Growth Rate | 33.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.26 | |||||
| 9-Day RSI | 30.69 | |||||
| 14-Day RSI | 36.92 | |||||
| 6-1 Month Momentum % | 23.77 | |||||
| 12-1 Month Momentum % | -23.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | |||||
| Quick Ratio | 4.15 | |||||
| Cash Ratio | 2.97 | |||||
| Days Inventory | 95.43 | |||||
| Days Sales Outstanding | 109.68 | |||||
| Days Payable | 62.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.65 | |||||
| Forward Dividend Yield % | 0.65 | |||||
| 5-Year Yield-on-Cost % | 0.68 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -4 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.28 | |||||
| Operating Margin % | -12.2 | |||||
| Net Margin % | -6.08 | |||||
| FCF Margin % | -21.74 | |||||
| ROE % | -2.33 | |||||
| ROA % | -1.63 | |||||
| ROIC % | -6.75 | |||||
| ROC (Joel Greenblatt) % | -5.98 | |||||
| ROCE % | -2.06 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.21 | |||||
| PB Ratio | 2.1 | |||||
| Price-to-Tangible-Book | 2.22 | |||||
| EV-to-EBIT | -71.5 | |||||
| EV-to-EBITDA | -71.5 | |||||
| EV-to-Revenue | 4.78 | |||||
| EV-to-FCF | -25.35 | |||||
| Price-to-Net-Current-Asset-Value | 5.65 | |||||
| Price-to-Net-Cash | 29.77 | |||||
| Earnings Yield (Greenblatt) % | -1.4 | |||||
| FCF Yield % | -4.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tibet Duo Rui Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 288.563 | ||
| EPS (TTM) (Â¥) | -0.21 | ||
| Beta | 0.65 | ||
| Volatility % | 42.46 | ||
| 14-Day RSI | 36.92 | ||
| 14-Day ATR (Â¥) | 0.926069 | ||
| 20-Day SMA (Â¥) | 21.02 | ||
| 12-1 Month Momentum % | -23.51 | ||
| 52-Week Range (Â¥) | 12.6 - 27.56 | ||
| Shares Outstanding (Mil) | 80 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tibet Duo Rui Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tibet Duo Rui Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tibet Duo Rui Pharmaceutical Co Ltd Frequently Asked Questions
What is Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075)'s stock price today?
The current price of SZSE:301075 is ¥19.05. The 52 week high of SZSE:301075 is ¥27.56 and 52 week low is ¥12.60.
When is next earnings date of Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075)?
The next earnings date of Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) is .
Does Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) pay dividends? If so, how much?
The Dividend Yield %  of Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) is 0.65% (As of Today), Highest Dividend Payout Ratio of Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) was 6.25. The lowest was 6.25. And the median was 6.25. The  Forward Dividend Yield % of Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) is 0.65%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers